Biotechnology

Techseriesinsight > Blog > News > Biotechnology

July 23, 2025
PRNewswire
Biotechnology, News

Dash Bio Raises $11M for Bioanalysis Tech

Dash Bio, a preclinical and clinical bioanalysis company reinventing the speed and scalability of drug development, today announced it has raised an additional $11 million in funding, bringing its total raised...

July 22, 2025
PRNewswire
Biotechnology, News

Codagenix to Develop Oral Polio Vaccine

Codagenix Inc., a clinical-stage biotechnology company, today announced a collaboration agreement with PATH funded by a grant from the Gates Foundation to apply its proprietary synthetic biology technology to...

July 22, 2025
PRNewswire
Biotechnology, Joint Ventures, News

Novella and Metaphor Foods Unite to Commercialize Cell-Based Natural Preservatives

Biotech start-up Novella Innovative Technology, Ltd. and leading functional ingredient innovators Metaphor Foods, Braeside Victoria, Australia, announce a strategic partnership to spearhead a new paradigm for natural preservation in food applications. Plant-cell...

July 22, 2025
PRNewswire
Biotechnology, Healthcare, News

First Patient Dosed in DOC1021 Phase 2 Trial

Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced that the first patient has been dosed in...

July 22, 2025
PRNewswire
Biotechnology, Networking, News

Nanoscope Shares Opsin Tech Insights

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene therapies for patients suffering vision loss from retinal degenerative diseases, today announced the publication of a...

July 21, 2025
PRNewswire
Biotechnology, News

Compugen Doses First Ovarian Cancer Patient

Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery powered by AI/ML, today announced that the first patient was dosed in the...

July 21, 2025
Business Wire
Biotechnology, Healthcare, News

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer

Positive high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy demonstrated a...

July 21, 2025
PRNewswire
Biotechnology, News

Synthego Announces Successful Close of Acquisition by Perceptive Advisors

Synthego, a leading provider of CRISPR solutions, today announced the successful closing of the acquisition of substantially all of its assets by funds managed by Perceptive Advisors, a leading...

July 18, 2025
PRNewswire
Biotechnology, News

Viatris Provides Update on Phase 3 Study of MR-139 for Blepharitis

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that a randomized, double-masked, vehicle-controlled, Phase 3 study to evaluate the efficacy and safety of pimecrolimus 0.3% (MR-139) ophthalmic ointment in subjects...

July 18, 2025
Business Wire
Biotechnology, News

BMS Reveals Reblozyl Phase 3 Results

Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 INDEPENDENCE trial evaluating Reblozyl (luspatercept-aamt) with concomitant janus kinase inhibitor (JAKi) therapy in adult patients with myelofibrosis-associated anemia receiving red blood...